Objective: In pigs, the infarct size (IS) reduction achieved by a strong preconditioning stimulus (IPs) of 10 min ischemia and 15 min reperfusion is greater than that by a weaker preconditioning stimulus (IPw) of 3 min ischemia and 15 min reperfusion 
Introduction
ly, in pigs in which infarct size reduction by IP was less pronounced with a preconditioning stimulus of 3 min The reduction of infarct size by ischemic preconditionpreconditioning ischemia and 15 min reperfusion than with ing (IP) is the most powerful endogenous cardioprotective a stronger preconditioning stimulus of 10 min precondiphenomenon known so far, and it is present in all species tioning ischemia and 15 min reperfusion, bradykinin was tested so far [1, 2] , including humans [3] . Goto et al. [4] of major importance only with the weaker preconditioning were the first to demonstrate the interaction of different stimulus while adenosine [5] and opioids [6] were of triggers with variation of the preconditioning protocol. In greater importance with a stronger preconditioning their study, bradykinin was of major importance only stimulus. during a weaker preconditioning stimulus, i.e., a single Activation of bradykinin-B -receptors subsequently acti-2 cycle of 5 min preconditioning ischemia and 5 min vates cyclooxygenase [7, 8] . Indeed, cyclooxygenase prodreperfusion, while during a strong preconditioning ucts are involved in the antiarrhythmic effect [9] and the stimulus, i.e., four cycles of preconditioning ischemia / preservation of endothelial function by ischemic preconreperfusion, adenosine was of greater importance. Similarditoning [10] . We therefore now tested in an established pig model of ischemic preconditioning whether or not inhibition of cyclooxygenase with indomethacin at this dose abolishes the infarct size reduction by ischemic namics and regional myocardial function and blood flow, preconditioning, and whether or not the loss of protection coronary inflow was reduced to achieve a 90% reduction in depends on the strength of the preconditioning stimulus regional myocardial function. At 5 and 85 min ischemia, and thus on the specific triggers involved in the cardiomeasurements were repeated, and thereafter the myocarprotective effect.
dium was reperfused for 2 h.
Group 2 (IP3, n57)

Methods
Following control measurements of systemic hemodynamics and regional myocardial function and blood flow, The experimental protocols employed in this study were the myocardium was subjected to one cycle of 3 min approved by the bioethical committee of the district of preconditioning ischemia, with a 90% reduction in regional Dusseldorf, Germany, and they adhere to the guiding myocardial function, and 15 min reperfusion. During principles of the American Physiological Society.
reperfusion, coronary arterial pressure was maintained at the level measured prior to ischemia by continuously 2.1. Experimental preparation adapting coronary inflow with the roller pump. Following reperfusion, coronary inflow was once again reduced to thë Forty-two Gottinger minipigs (20-40 kg) of either sex same level as during the preconditioning ischemia. Therewere initially sedated using ketamine hydrochloride (1 g after, the protocol of group 2 was identical to that of group i.m.) and then anesthetized with thiopental (Trapanal, 500
1. mg i.v., Byk Gulden, Konstanz, Germany). Through a midline cervical incision, the trachea was intubated forc onnection to a respirator (Drager, Lubeck, Germany). 2.4.3. Group 3 (IP10, n57) Anesthesia was then maintained using enflurane (1-1.5%)
The protocol of group 3 was identical to that of group 2, with an oxygen-nitrous oxide (40:60) mixture. Arterial except that the preconditioning ischemia was of 10 min blood gases were monitored frequently in the initial stages duration. of the preparation until stable and then periodically throughout the study (Radiometer, Copenhagen, Denmark).
2.4.4. Group 4 (Indo, n57) Rectal temperature was monitored, and body temperature Following control measurements of systemic hemodywas kept between 37 and 388C using heating pads. Pigs namics and regional myocardial function and blood flow, were instrumented for the measurement of left ventricular cyclooxygenase was inhibited by intravenous infusion of pressure and wall thickness [5, 11] . After heparinization, 10 mg / kg indomethacin over 30 min. This dose regimen the left anterior descending (LAD) coronary artery and has previously been demonstrated to abolish the coronary vein were cannulated, and the artery was perfused from an vasodilation induced by intracoronary arachidonic acid [8] . extracorporeal circuit, including a roller pump. During
After infusion of indomethacin all measurements were ischemia, blood flow into the cannulated LAD coronary repeated before coronary inflow was reduced. Thereafter artery was reduced (see below) by reducing the speed of the protocol of group 4 was identical to that of group 1. the roller pump; however, a residual blood flow of approximately 15-20% was always maintained.
2.4.5. Group 5 (Indo1IP3, n56)
Regional myocardial function and regional
The protocol of group 5 was identical to that of group 2, myocardial blood flow except that the indomethacin administration (10 mg / kg i.v.) was started 30 min prior to the preconditioning Regional systolic wall thickening was determined using ischemia. sonomicrometry, and regional myocardial blood flow was measured with radioactive microspheres [12] .
2.4.6. Group 6 (Indo1IP10, n57)
The protocol of group 6 was identical to that of group 3, 2.3. Morphology except that the indomethacin administration (10 mg / kg i.v.) was started 30 min prior to the preconditioning Up to six transverse myocardial slices from each heart ischemia. were incubated in triphenyl tetrazolium chloride solution to identify necrotic tissue [5] Heart rate was held constant by left atrial pacing. In groups 1-6, linear regression analyses between Systemic hemodynamics, regional myocardial function, subendocardial blood flow at 5 min ischemia in the left and regional myocardial blood flow were not different ventricular area at risk and infarct size (expressed as between groups 1 to 6 at baseline (Table 1) . Regional percent of the area at risk) were performed. Regression myocardial function of the posterior control wall remained lines were compared by analysis of covariance.
stable throughout the experimental protocol in each group. G1: 90 min severe ischemia, (n58); G2: IP3 (preconditioning stimulus: 3 min ischemia and 15 min reperfusion)190 min severe ischemia (n57); G3: IP10 (preconditioning stimulus: 10 min ischemia and 15 min reperfusion)190 min severe ischemia (n57); G4: indomethacin190 min severe ischemia (n57); G5: indomethacin1IP3190 min severe ischemia (n56); G6: indomethacin1IP10190 min severe ischemia (n57), HR: heart rate (beats / min); LVPP: left ventricular peak pressure (mmHg); dP/dt: maximum of the first derivative of left ventricular pressure (mmHg / s); CAP: coronary arterial pressure (mmHg); TMBF: transmural myocardial blood flow (ml / min / g); AWT: anterior systolic wall thickening (% In groups 4 to 6 indomethacin increased LV peak pressure and mean coronary arterial pressure, whereas anterior systolic wall thickening was decreased. Indomethacin per se did not alter transmural myocardial blood flow.
Infarct size
The area at risk was comparable between groups 1 to 6 (Fig. 1) . Following 90 min severe myocardial ischemia and 120 min reperfusion, infarct size averaged 25.563. 8%  (group 1, Fig. 1 ). IP by one cycle of 3 min ischemia and 15 min reperfusion reduced infarct size to 6.362.1% (group 2, p,0.05 vs. group 1). IP by one cycle of 10 min Infarct size was significantly reduced in hearts preconditioned by 3 min Fig. 3 . Relationships between infarct size and subendocardial blood flow ischemia and 15 min reperfusion (group 2) and further reduced by 10 Ischemic blood flow is another major determinant of infarct development [15] , and therefore the relation of infarct size to subendocardial blood flow is a more sensitive endpoint than infarct size per se. Indeed, mean infarct size did not significantly differ between the three indomethacin-treated groups, although the blood flow-infarct size relationship revealed a complete loss of preconditoning's protection only in hearts with a weaker preconditioning stimulus (IP3), but a loss of protection in only two out of seven hearts with a stronger preconditioning stimulus (IP10). prostaglandin E and to a smaller amount PGF was 2 2 a measured, which was increased during hypoxia [16] . In 4. Discussion isolated rabbit hearts [17] , bradykinin induced a prostaglandin release, the most important cyclooxygenase-prodThe major finding of the present study is that prostaucts being prostaglandin I (70%) and E (30%). Apart 2 2 glandins are involved in the signal cascade of ischemic from isolated cardiomyocytes [16] , vascular endothelial preconditioning in pigs, their involvement depending on and smooth muscle cells [7] produce prostaglandins. The the strength of the preconditioning stimulus. Whereas signal cascade involves G-proteins, inositoltriphosphate inhibition of cyclooxygenase with indomethacin (10 mg / and diacylglycerol, and subsequently protein kinase C kg) completely abolished the infarct size reduction activation [7] . achieved by a weaker preconditioning stimulus (IP3), it abolished infarct size reduction by a stronger precondition-4.4. Comparison to other studies ing stimulus (IP10) in only two of seven pigs. Thus, with stronger preconditioning stimuli other triggers / mediators
Source and nature of prostaglandins
In contrast to the present study, endogenous prostacan compensate for the lack of prostaglandins. glandins appear to be not involved in the infarct size reduction by ischemic preconditoning in rats and rabbits, 4.1. Critique of methods since aspirin or indomethacin failed to block preconditioning's protection [18, 19] . The failure of blockade of cycloThe strengths and limitations of the experimental model oxygenase to attenuate infarct size reduction by ischemic have been discussed in detail elsewhere [5] .
preconditioning in rats might relate to the greater strength Indomethacin increased left ventricular pressure and of the preconditioning stimulus with three cycles of 3 min mean coronary arterial pressure. The latter finding is in ischemia and 15 min reperfusion [18] , and thus the accordance with studies in conscious dogs, in which a involvement of additional triggers. The failure of blockade basal tonic release of prostaglandins -measured as the of cyclooxygenase to attenuate ischemic preconditioning's release of PGF -was reported, and blockade of such protection in isolated rabbit hearts [19] , however, is less 1a release with either indomethacin (5 mg / kg) or diclofenac likely be related to the strength of the preconditioning (10 mg / kg) increased smooth muscle tone and subsequentstimulus. In this model, with a single preconditioning ly coronary perfusion pressure [13] .
episode of 5 min ischemia / reperfusion, bradykinin preferentially triggers the observed cardioprotection, which is 4.2. Determinants of infarct size blocked by the bradykinin-B -receptor antagonist HOE140 2
[4]. As mentioned above, indomethacin increased left venOne potential explanation for the lack of blockade of tricular pressure but did not alter infarct size (groups 1 and ischemic preconditioning's protection by either in-4). This finding is in agreement with results from previous domethacin alone [19] or the NO-synthase inhibitor Lexperiments in which increases in left ventricular pressure NAME alone [20] is their cooperative action. Indeed, in at a constant heart rate and myocardial blood flow did not isolated rabbit hearts, bradykinin infusion increases both influence the extent of myocardial infarction [14] . nitric oxide (measured as an increase in cGMP) and prostaglandin (measured as 6-keto-PGF ) release [17] . stronger preconditioning stimulus in five out of seven pigs. The loss of protection in two out of seven pigs, however, Pharmacological preconditioning with bradykinin reduced points to the fact that the interaction of different triggers / infarct size, which was, however, not affected by the mediators in ischemic preconditioning is quite complex, blockade of cyclooxygenase with indomethacin alone nor and that interindividual variations exist; such interindividuthe blockade of nitric oxide synthase with L-NAME alone.
al variations were recently also demonstrated for the Unfortunately, combined blockade of both cyclooxygenase ischemia-induced phosphorylation of p38 MAP kinase in and nitric oxide synthase was not performed. A cooperathe same pig model [32] . tive signal transduction has been previously demonstrated
In conclusion, prostaglandins are involved in ischemic for protein kinase C and protein tyrosine kinases in rats preconditioning in pigs. However, with stronger precondiand pigs (for review, see Ref. [21] ).
tioning stimuli other triggers / mediators can compensate An alternative, although purely speculative explanation for the lack of prostaglandins. Whereas the present study relates to the concentration of the blocker used to inhibit clearly identifies the involvement of prostaglandins in cyclooxygenase; in this respect, aspirin at a dose of 1 ischemic preconditioning, their cellular and subcellular mg / kg [19] failed to block the protective effect of ACEsource as well as their exact location in the signal inhibitors on myocardial stunning in anesthetized dogs transduction cascade of ischemic preconditioning remain to [22] , whereas indomethacin at a dose of 10 mg / kg be defined. completely abolished this protection [8] .
Triggers /mediators of ischemic preconditioning
